The consistent fat depth in this region promotes stable, predictable medication absorption compared to areas with variable tissue composition
Following semaglutide, numerous anti-obesity drugs have been developed to improve the pharmacological properties of GLP-1 RAs, such as prolonging appetite suppression, increasing potency, or mitigating adverse effects, including gastrointestinal symptoms and lean mass loss [34, 35]
10.1007/s12668-025-02010-5 200
As the active ingredient in Wegovy and other GLP-1 medications, semaglutide triggers changes inside your body that help you finally lose excess weight
they are also known as nutrient-stimulated hormones
We do not provide dosage, administration, injection, or usage guidance, in line with our policy